Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For ALTR.LS
Valuation Somewhat Weak
43%
Profitability n.A.
Fin. Growth Weak
33%
Leverage & Liquidity Weak
33%
Per Share Metrics Weak
33%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q3 Q4 Δ in %
Current Ratio 18.77 2.17 1.83
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -49.45 7.83 15.49
Naive Interpretation member
2 Per Share
Metric Q3 Q4 Δ in %
Book Value 3.77 2.06 1.99
Cash -23.88 0.95 1.24
Capex n.A. n.A. -0.04
Free Cash Flow n.A. n.A. 0.15
Revenue 25.97 1.09 0.86
Naive Interpretation member
3 Profitability
Metric Q3 Q4 Δ in %
Gross Margin 208.36 0.17 0.06
Operating Margin 119.53 0.17 0.08
ROA 49.38 0.02 0.01
ROE 37.51 0.05 0.04
ROIC 172.34 0.03 0.01
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of ALTR.LS is permitted for members.
5 Growth
The "Growth Entry" for the Focus of ALTR.LS is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of ALTR.LS is permitted for members.